These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 2943685

  • 1. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S, Alaimo G, Abrignani MG, Giordano U, Avellone G, Pinto A, Adamo L, Cutietta A, Indovina A, Strano A.
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [Abstract] [Full Text] [Related]

  • 2. Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
    Strano A, Novo S, Raineri A, Alaimo G, Abrignani MG, Cutietta A.
    J Hypertens Suppl; 1986 Apr; 4(1):S103-6. PubMed ID: 2939208
    [Abstract] [Full Text] [Related]

  • 3. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S, Alaimo G, Giordano U, Raineri A, Strano A.
    J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension.
    Novo S, Pinto A, Galati D, Giannola A, Forte G, Strano A.
    Int Angiol; 1985 Apr; 4(2):229-34. PubMed ID: 2870124
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A, Fagard R, Fiocchi R, Lijnen P, Staessen J, Vermylen J.
    J Cardiovasc Pharmacol; 1984 Apr; 6(1):182-5. PubMed ID: 6199602
    [Abstract] [Full Text] [Related]

  • 6. [Essential arterial hypertension and Leriche-Fontaine stage II obliterating vascular disease of the lower limbs. A new pharmacological approach with ketanserin].
    Mollo P.
    Clin Ter; 1991 Apr 30; 137(2):113-5. PubMed ID: 1828404
    [Abstract] [Full Text] [Related]

  • 7. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L, Svensson A, Dahlöf B, Eggertsen R, Hansson L.
    Acta Med Scand; 1983 Apr 30; 214(2):125-30. PubMed ID: 6353879
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 30; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 9. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B, Elmér O, Akesson A.
    Int Angiol; 1988 Apr 30; 7(1):19-25. PubMed ID: 3290356
    [Abstract] [Full Text] [Related]

  • 10. Ketanserin in the treatment of mild hypertension in elderly patients: preliminary results of a controlled double-blind trial.
    Dona G, Ribeiro A, Tammaro AE.
    J Hypertens Suppl; 1986 Apr 30; 4(1):S89-90. PubMed ID: 2939220
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R, Andreoni A, Saccomanno G, Gambini C, Paciaroni E.
    Drugs Exp Clin Res; 1989 Apr 30; 15(11-12):577-81. PubMed ID: 2700320
    [Abstract] [Full Text] [Related]

  • 12. Comparison of ketanserin and pindolol in hypertension.
    Gordin A, Saraste K, Turanlahti M, Sundberg S.
    J Hypertens Suppl; 1986 Apr 30; 4(1):S61-2. PubMed ID: 2939214
    [Abstract] [Full Text] [Related]

  • 13. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H.
    J Hypertens Suppl; 1986 Apr 30; 4(1):S73-5. PubMed ID: 2939217
    [Abstract] [Full Text] [Related]

  • 14. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A, Ceccanti M, Assogna G, Romeo M, Cavaleri G, Attilia ML.
    Int J Clin Pharmacol Res; 1988 Apr 30; 8(5):321-5. PubMed ID: 3068159
    [Abstract] [Full Text] [Related]

  • 15. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G, Gradoli C, Proietti MG, Pinchi G, Fioroni E, Valori C.
    Clin Ter; 1989 Jul 31; 130(2):101-7. PubMed ID: 2529082
    [Abstract] [Full Text] [Related]

  • 16. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T, Persson B.
    J Cardiovasc Pharmacol; 1988 Jul 31; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [Abstract] [Full Text] [Related]

  • 17. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
    Klieber M, Resch F.
    Wien Klin Wochenschr; 1986 Feb 07; 98(3):70-3. PubMed ID: 2938341
    [Abstract] [Full Text] [Related]

  • 18. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J, Koehle W, Gruebel B, Fisher R.
    J Hypertens Suppl; 1986 Apr 07; 4(1):S85-7. PubMed ID: 2871145
    [Abstract] [Full Text] [Related]

  • 19. [Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].
    Rizzoni D, Castellano M, Beschi M, Agabiti-Rosei E.
    Ann Ital Med Int; 1990 Apr 07; 5(4 Pt 2):489-96. PubMed ID: 2102136
    [Abstract] [Full Text] [Related]

  • 20. Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.
    Lepäntalo MJ, Tötterman KJ.
    Int Angiol; 1985 Apr 07; 4(2):225-8. PubMed ID: 3831144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.